difluprednate (ophthalmic)

Absorption: Limited systemic absorption.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

ROUTE	ONSET	PEAK	DURATION
Ophth	unknown	unknown	unknown

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Active viral, mycobacterial or fungal infection of eyes and surrounding structures.

Use Cautiously in:

OB: Use in pregnancy only if potential benefit justifies potential risk to the fetus;
Lactation: Use cautiously during lactation;
Pedi: Safety and effectiveness in children have not been established.

Adv. Reactions/Side Effects ⬆ ⬇

EENT: ↑intraocular pressure, blepharitis, cataracts, conjunctival hyperemia, corneal edema, delayed healing, eye pain, infections, iritis, photophobia

Interactions ⬆ ⬇

Drug-drug:

None noted.

Route/Dosage ⬆ ⬇

(Adults ): 1 drop four times daily, starting 24 hr after surgery for 2 wk, then twice daily for one week, then further tapered based on response.

Availability ⬆ ⬇

Ophthamic emulsion: 0.05% in 5 mL bottle

Assessment ⬆ ⬇

Assess affected eye for pain and swelling during therapy.
Monitor intraocular pressure of difluprednate is used more than 10 days.

Implementation ⬆ ⬇

Instill 1 drop into conjunctival sac of affected eye 4 times/day beginning 24 hrs after surgery and continuing throughout first 2 wks of postoperative period, followed by twice daily for a wk, then base dose on patient response.

Patient/Family Teaching ⬆ ⬇

Instruct patient in correct technique and frequency for instillation of eye drops (see Medication Administration Techniques).
Instruct patient to avoid wearing contact lenses during therapy.
Advise female patients to notify health care professional if pregnancy is planned or suspected or if breastfeeding.
Advise patient to notify health care professional if redness, itching or inflammation develops or becomes aggravated.

Evaluation/Desired Outcomes ⬆ ⬇

Decrease in eye pain and inflammation following ocular surgery.

US Brand Names ⬆ ⬇

Code ⬆

NDC Code

0078- Novartis Pharmaceuticals Corporation
- 0078-0862- DUREZOL
  - 0078-0862-25- 1 BOTTLE in 1 CARTON (0078-0862-25) / 5 mL in 1 BOTTLE

26251- Tianjin Pacific Chemical and Pharmaceutical Co. Ltd.
- 26251-0003-
  - 26251-0003-1- 1000 g in 1 BAG (26251-0003-1)

46439- Farmabios S.p.A.
- 46439-8738-
  - 46439-8738-1- 5000 g in 1 DRUM (46439-8738-1)

46439- Farmabios S.p.A.
- 46439-8739-
  - 46439-8739-1- 5000 g in 1 DRUM (46439-8739-1)

46439- Farmabios S.p.A.
- 46439-8739-
  46439-8739-2- 10 g in 1 CARTON (46439-8739-2)

49803- Steroid S.p.A.
- 49803-002-
  49803-002-01- 2 BAG in 1 CONTAINER (49803-002-01) / 25000 g in 1 BAG

65145- Caplin Steriles Limited
- 65145-161- Difluprednate
  65145-161-01- 1 BOTTLE in 1 CARTON (65145-161-01) / 5 mL in 1 BOTTLE

66758- Sandoz Inc
- 66758-086- DUREZOL
  - 66758-086-75- 1 BOTTLE in 1 CARTON (66758-086-75) / 5 mL in 1 BOTTLE

69097- Cipla USA Inc.
- 69097-341- DIFLUPREDNATE
  - 69097-341-35- 1 BOTTLE in 1 CARTON (69097-341-35) / 5 mL in 1 BOTTLE

69315- Leading Pharma, LLC
- 69315-329- DIFLUPREDNATE
  - 69315-329-05- 1 BOTTLE in 1 CARTON (69315-329-05) / 5 mL in 1 BOTTLE

section name header

Pronunciation ⬇

Classifications ⬆ ⬇

Indications ⬆ ⬇

Action ⬆ ⬇

Pharmacokinetics ⬆ ⬇